Skip to main content

Falls and Impaired Mobility

  • Chapter
  • First Online:
Optimizing Pharmacotherapy in Older Patients

Part of the book series: Practical Issues in Geriatrics ((PIG))

  • 588 Accesses

Abstract

Falls are a rapidly growing global public health problem. Mostly falls result from several interacting risk factors, and key risk factors include impaired mobility and use of certain medications (fall risk-increasing drugs, FRIDs). In fact, falls are a common and often overlooked adverse drug event (ADE) in older persons. In this chapter, the evidence regarding FRIDs is being presented as well as the possible mechanisms why FRID use can lead to falls including cardiovascular, motoric, and central nervous system related ADEs. Special attention is given toward potential adverse effects of medication use on mobility. Finally, the evidence regarding the effectiveness of deprescribing (both as a single and as a part of multifactorial intervention) are being discussed, and practical guidance regarding medication management in older persons at risk for falls is given.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Berry SD, Miller RR. Falls: epidemiology, pathophysiology, and relationship to fracture. Curr Osteoporos Rep. 2008;6(4):149–54.

    PubMed  PubMed Central  Google Scholar 

  2. Montero-Odasso M, van der Velde N, Alexander NB, Becker C, Blain H, Camicioli R, et al. New horizons in falls prevention and management for older adults: a global initiative. Age Ageing. 2021;50(5):1499–507.

    PubMed  Google Scholar 

  3. Morris R, O’Riordan S. Prevention of falls in hospital. Clin Med (Lond). 2017;17(4):360–2.

    PubMed  Google Scholar 

  4. Bouldin EL, Andresen EM, Dunton NE, Simon M, Waters TM, Liu M, et al. Falls among adult patients hospitalized in the United States: prevalence and trends. J Patient Saf. 2013;9(1):13–7.

    PubMed  PubMed Central  Google Scholar 

  5. Step safely: strategies for preventing and managing falls across the life-course. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO.

    Google Scholar 

  6. Milat AJ, Watson WL, Monger C, Barr M, Giffin M, Reid M. Prevalence, circumstances and consequences of falls among community-dwelling older people: results of the 2009 NSW falls prevention baseline survey. N S W Public Health Bull. 2011;22(3–4):43–8.

    PubMed  Google Scholar 

  7. Heinrich S, Rapp K, Rissmann U, Becker C, König H-H. Cost of falls in old age: a systematic review. Osteoporos Int. 2010;21(6):891–902.

    CAS  PubMed  Google Scholar 

  8. Ganz DA, Latham NK. Prevention of falls in community-dwelling older adults. N Engl J Med. 2020;382(8):734–43.

    PubMed  Google Scholar 

  9. Deandrea S, Lucenteforte E, Bravi F, Foschi R, La Vecchia C, Negri E. Risk factors for falls in community-dwelling older people: a systematic review and meta-analysis. Epidemiology. 2010;21(5):658–68.

    PubMed  Google Scholar 

  10. Kyrdalen IL, Thingstad P, Sandvik L, Ormstad H. Associations between gait speed and well-known fall risk factors among community-dwelling older adults. Physiother Res Int. 2019;24(1):e1743.

    PubMed  Google Scholar 

  11. Verghese J, LeValley A, Hall CB, Katz MJ, Ambrose AF, Lipton RB. Epidemiology of gait disorders in community-residing older adults. J Am Geriatr Soc. 2006;54(2):255–61.

    PubMed  PubMed Central  Google Scholar 

  12. Pirker W, Katzenschlager R. Gait disorders in adults and the elderly : a clinical guide. Wien Klin Wochenschr. 2017;129(3–4):81–95.

    PubMed  Google Scholar 

  13. Osman A, Kamkar N, Speechley M, Ali S, Montero-Odasso M. Fall risk-increasing drugs and gait performance in community-dwelling older adults: a systematic review. Ageing Res Rev. 2022;77:101599.

    CAS  PubMed  Google Scholar 

  14. Nnodim JO, Yung RL. Balance and its clinical assessment in older adults—A review. J Geriatr Med Gerontol. 2015;1(1):003.

    PubMed  PubMed Central  Google Scholar 

  15. Moreland JD, Richardson JA, Goldsmith CH, Clase CM. Muscle weakness and falls in older adults: a systematic review and meta-analysis. J Am Geriatr Soc. 2004;52(7):1121–9.

    PubMed  Google Scholar 

  16. Seene T, Kaasik P. Muscle weakness in the elderly: role of sarcopenia, dynapenia, and possibilities for rehabilitation. Eur Rev Aging Phys Act. 2012;9(2):109–17.

    Google Scholar 

  17. Hart LA, Phelan EA, Yi JY, Marcum ZA, Gray SL. Use of fall risk-increasing drugs around a fall-related injury in older adults: a systematic review. J Am Geriatr Soc. 2020;68(6):1334–43.

    PubMed  PubMed Central  Google Scholar 

  18. Stam H, Harting T, van der Sluijs M, van Marum R, van der Horst H, van der Wouden JC, et al. Usual care and management of fall risk increasing drugs in older dizzy patients in Dutch general practice. Scand J Prim Health Care. 2016;34(2):164–70.

    PubMed Central  Google Scholar 

  19. Shaver AL, Clark CM, Hejna M, Feuerstein S, Wahler RG Jr, Jacobs DM. Trends in fall-related mortality and fall risk increasing drugs among older individuals in the United States,1999–2017. Pharmacoepidemiol Drug Saf. 2021;30(8):1049–56.

    PubMed  PubMed Central  Google Scholar 

  20. Seppala LJ, van der Velde N, Masud T, Blain H, Petrovic M, van der Cammen TJ, et al. EuGMS Task and Finish group on Fall-Risk-Increasing Drugs (FRIDs): position on knowledge dissemination, management, and future research. Drugs Aging. 2019;36(4):299–307.

    CAS  PubMed  PubMed Central  Google Scholar 

  21. de Vries M, Seppala LJ, Daams JG, van de Glind EMM, Masud T, van der Velde N. Fall-risk-increasing drugs: a systematic review and meta-analysis: I. Cardiovascular drugs. J Am Med Dir Assoc. 2018;19(4):371.e1–9.

    PubMed  Google Scholar 

  22. Seppala LJ, van de Glind EMM, Daams JG, Ploegmakers KJ, de Vries M, Wermelink A, et al. Fall-risk-increasing drugs: a systematic review and meta-analysis: III. Others. J Am Med Dir Assoc. 2018;19(4):372.e1–8.

    PubMed  Google Scholar 

  23. Seppala LJ, Wermelink A, de Vries M, Ploegmakers KJ, van de Glind EMM, Daams JG, et al. Fall-risk-increasing drugs: a systematic review and meta-analysis: II. Psychotropics. J Am Med Dir Assoc. 2018;19(4):371.e11–7.

    PubMed  Google Scholar 

  24. Seppala LJ, Petrovic M, Ryg J, Bahat G, Topinkova E, Szczerbińska K, et al. STOPPFall (Screening Tool of Older Persons Prescriptions in older adults with high fall risk): a Delphi study by the EuGMS Task and Finish Group on Fall-Risk-Increasing Drugs. Age Ageing. 2020;50:1189.

    PubMed Central  Google Scholar 

  25. Rivasi G, Kenny RA, Ungar A, Romero-Ortuno R. Effects of benzodiazepines on orthostatic blood pressure in older people. Eur J Intern Med. 2020;72:73–8.

    CAS  PubMed  Google Scholar 

  26. Capiau A, Huys L, van Poelgeest E, van der Velde N, Petrovic M, Somers A. Therapeutic dilemmas with benzodiazepines and Z-drugs: insomnia and anxiety disorders versus increased fall risk—a clinical review. Eur Geriatr Med. 2022.

    Google Scholar 

  27. Stroup TS, Gray N. Management of common adverse effects of antipsychotic medications. World Psychiatry. 2018;17(3):341–56.

    PubMed  PubMed Central  Google Scholar 

  28. Korkatti-Puoskari N, Tiihonen M, Caballero-Mora MA, Topinkova E, Szczerbińska K, Hartikainen S. Therapeutic dilemma’s: antipsychotics and risk of falling in older adults: a clinical review. Under review.

    Google Scholar 

  29. van Poelgeest EP, Pronk AC, Rhebergen D, van der Velde N. Depression, antidepressants and fall risk: therapeutic dilemmas—a clinical review. Eur Geriatr Med. 2021;12(3):585–96.

    PubMed  PubMed Central  Google Scholar 

  30. Weinberger MH. Diuretics and their side effects. Dilemma in the treatment of hypertension. Hypertension. 1988;11(3 Pt 2):II16–20.

    CAS  PubMed  Google Scholar 

  31. Carruthers SG. Adverse effects of α1-adrenergic blocking drugs. Drug Saf. 1994;11(1):12–20.

    CAS  PubMed  Google Scholar 

  32. Sica DA. Centrally acting antihypertensive agents: an update. J Clin Hypertens (Greenwich). 2007;9(5):399–405.

    CAS  PubMed  Google Scholar 

  33. Thadani U, Rodgers T. Side effects of using nitrates to treat angina. Expert Opin Drug Saf. 2006;5(5):667–74.

    CAS  PubMed  Google Scholar 

  34. Virnes RE, Tiihonen M, Karttunen N, van Poelgeest EP, van der Velde N, Hartikainen S. Opioids and falls risk in older adults: a narrative review. Drugs Aging. 2022;39(3):199–207.

    PubMed  PubMed Central  Google Scholar 

  35. Perucca P, Gilliam FG. Adverse effects of antiepileptic drugs. Lancet Neurol. 2012;11(9):792–802.

    CAS  PubMed  Google Scholar 

  36. Nishtala PS, Salahudeen MS, Hilmer SN. Anticholinergics: theoretical and clinical overview. Expert Opin Drug Saf. 2016;15(6):753–68.

    CAS  PubMed  Google Scholar 

  37. Chapple CR. A comparison of varying alpha-blockers and other pharmacotherapy options for lower urinary tract symptoms. Rev Urol. 2005;7 Suppl 4(Suppl 4):S22–30.

    PubMed  Google Scholar 

  38. Ilhan B, Erdoğan T, Topinkova E, Bahat G. Management of commonly used urinary incontinence and benign prostatic hyperplasia drugs in older adults at risk of falls: a clinical review. Under review.

    Google Scholar 

  39. Lam S, Hilas O. Pharmacologic management of overactive bladder. Clin Interv Aging. 2007;2(3):337–45.

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Kaliner MA. H1-antihistamines in the elderly. Clin Allergy Immunol. 2002;17:465–81.

    CAS  PubMed  Google Scholar 

  41. O'Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8.

    PubMed  Google Scholar 

  42. American Geriatrics Society 2019 updated AGS beers criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–94.

    Google Scholar 

  43. van der Velde N, van den Meiracker AH, Pols HA, Stricker BH, van der Cammen TJ. Withdrawal of fall-risk-increasing drugs in older persons: effect on tilt-table test outcomes. J Am Geriatr Soc. 2007;55(5):734–9.

    PubMed  Google Scholar 

  44. van der Velde N, Stricker BH, Pols HA, van der Cammen TJ. Withdrawal of fall-risk-increasing drugs in older persons: effect on mobility test outcomes. Drugs Aging. 2007;24(8):691–9.

    PubMed  Google Scholar 

  45. Neutel CI, Hirdes JP, Maxwell CJ, Patten SB. New evidence on benzodiazepine use and falls: the time factor. Age Ageing. 1996;25(4):273–8.

    CAS  PubMed  Google Scholar 

  46. Ray WA, Thapa PB, Gideon P. Benzodiazepines and the risk of falls in nursing home residents. J Am Geriatr Soc. 2000;48(6):682–5.

    CAS  PubMed  Google Scholar 

  47. Gribbin J, Hubbard R, Gladman J, Smith C, Lewis S. Risk of falls associated with antihypertensive medication: self-controlled case series. Pharmacoepidemiol Drug Saf. 2011;20(8):879–84.

    PubMed  Google Scholar 

  48. Zazzara MB, Palmer K, Vetrano DL, Carfì A, Graziano O. Adverse drug reactions in older adults: a narrative review of the literature. Eur Geriatr Med. 2021;12(3):463–73.

    PubMed  PubMed Central  Google Scholar 

  49. Tinetti ME, Han L, Lee DS, McAvay GJ, Peduzzi P, Gross CP, et al. Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults. JAMA Intern Med. 2014;174(4):588–95.

    PubMed  PubMed Central  Google Scholar 

  50. Ham AC, Ziere G, Broer L, Swart KM, Enneman AW, van Dijk SC, et al. CYP2C9 genotypes modify benzodiazepine-related fall risk: original results from three studies with meta-analysis. J Am Med Dir Assoc. 2017;18(1):88.e1–88.e15.

    PubMed  Google Scholar 

  51. Montero-Odasso M, van der Velde N, Martin FC, Petrovic M, Tan MP, Ryg J, et al. World guidelines for falls prevention and management for older adults: a global initiative. Age Ageing. 2022;51(9):afac205.

    PubMed  PubMed Central  Google Scholar 

  52. Dautzenberg L, Beglinger S, Tsokani S, Zevgiti S, Raijmann R, Rodondi N, et al. Interventions for preventing falls and fall-related fractures in community-dwelling older adults: a systematic review and network meta-analysis. J Am Geriatr Soc. 2021;69:2973.

    PubMed  PubMed Central  Google Scholar 

  53. Lee J, Negm A, Peters R, Wong EKC, Holbrook A. Deprescribing fall-risk increasing drugs (FRIDs) for the prevention of falls and fall-related complications: a systematic review and meta-analysis. BMJ Open. 2021;11(2):e035978.

    PubMed  PubMed Central  Google Scholar 

  54. Cameron ID, Dyer SM, Panagoda CE, Murray GR, Hill KD, Cumming RG, et al. Interventions for preventing falls in older people in care facilities and hospitals. Cochrane Database Syst Rev. 2018;9(9):CD005465.

    PubMed  Google Scholar 

  55. Seppala LJ, Kamkar N, van Poelgeest EP, Thomsen K, Daams JG, Ryg J, et al. Medication reviews and deprescribing as a single intervention in falls prevention: a systematic review and meta-analysis. Age Ageing. 2022;51(9):afac191.

    PubMed  PubMed Central  Google Scholar 

  56. Hopewell S, Copsey B, Nicolson P, Adedire B, Boniface G, Lamb S. Multifactorial interventions for preventing falls in older people living in the community: a systematic review and meta-analysis of 41 trials and almost 20 000 participants. Br J Sports Med. 2020;54(22):1340–50.

    PubMed  Google Scholar 

  57. Iyer S, Naganathan V, McLachlan AJ, Le Conteur DG. Medication withdrawal trials in people aged 65 years and older. Drugs Aging. 2008;25(12):1021–31.

    PubMed  Google Scholar 

  58. Sawan M, Reeve E, Turner J, Todd A, Steinman MA, Petrovic M, et al. A systems approach to identifying the challenges of implementing deprescribing in older adults across different health-care settings and countries: a narrative review. Expert Rev Clin Pharmacol. 2020;13(3):233–45.

    CAS  PubMed  PubMed Central  Google Scholar 

  59. Tinetti ME, Gordon C, Sogolow E, Lapin P, Bradley EH. Fall-risk evaluation and management: challenges in adopting geriatric care practices. Gerontologist. 2006;46(6):717–25.

    PubMed  Google Scholar 

  60. Tsunoda K, Uchida H, Suzuki T, Watanabe K, Yamashima T, Kashima H. Effects of discontinuing benzodiazepine-derivative hypnotics on postural sway and cognitive functions in the elderly. Int J Geriatr Psychiatry. 2010;25(12):1259–65.

    PubMed  Google Scholar 

  61. Nurminen J, Puustinen J, Lähteenmäki R, Vahlberg T, Lyles A, Partinen M, et al. Handgrip strength and balance in older adults following withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotics. BMC Geriatr. 2014;14(1):121.

    PubMed  PubMed Central  Google Scholar 

  62. Shrank WH, Polinski JM, Avorn J. Quality indicators for medication use in vulnerable elders. J Am Geriatr Soc. 2007;55(s2):S373–S82.

    PubMed  Google Scholar 

  63. Medicines and older people: implementing medicines related aspects of the National Service Framework for older people. London: DoH: Department of Health; 2001.

    Google Scholar 

  64. NICE. Medicines management in care homes. Quality standard [QS85].

    Google Scholar 

  65. Beuscart JB, Pelayo S, Robert L, Thevelin S, Marien S, Dalleur O. Medication review and reconciliation in older adults. Eur Geriatr Med. 2021;12:499.

    PubMed  Google Scholar 

  66. Boye ND, van der Velde N, de Vries OJ, van Lieshout EM, Hartholt KA, Mattace-Raso FU, et al. Effectiveness of medication withdrawal in older fallers: results from the Improving Medication Prescribing to reduce Risk Of FALLs (IMPROveFALL) trial. Age Ageing. 2017;46(1):142–6.

    PubMed  Google Scholar 

  67. Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process. Br J Clin Pharmacol. 2014;78(4):738–47.

    PubMed  PubMed Central  Google Scholar 

  68. EuGMS. Task & Finish Groups. FRID—Fall Risk Increasing Drugs. https://www.eugms.org/research-cooperation/task-finish-groups/frid-fall-risk-increasing-drugs.html.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lotta Seppala .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Seppala, L., van der Velde, N. (2023). Falls and Impaired Mobility. In: Cherubini, A., Mangoni, A.A., O’Mahony, D., Petrovic, M. (eds) Optimizing Pharmacotherapy in Older Patients. Practical Issues in Geriatrics. Springer, Cham. https://doi.org/10.1007/978-3-031-28061-0_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-28061-0_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-28060-3

  • Online ISBN: 978-3-031-28061-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics